Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
RSC Medicinal Chemistry
|
December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitors
Jeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Detecting Alzheimer's disease using digital virtual reality cognitive tests
Lili Fang, Xiang Fan, Anqi Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies
Dai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 17, 2025
Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer's disease
Guoyu Lan, Laihong Zhang, Anqi Li, et al.
Alzheimer'S Research & Therapy
|
April 16, 2024
Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
Zhen Liu, Dai Shi, Yue Cai, et al.
Science Immunology
|
May 10, 2024
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Chuan Qin, Min Zhang, Da-Peng Mou, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
Journal of Medicinal Chemistry
|
November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors
Dai-Shi Su, Junya Qu, Mark Schulz, et al.
European Journal of Pharmacology
|
September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist
Richard W Ransom, Charles M Harrell, Duane R Reiss, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
RSC Medicinal Chemistry
|
December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitors
Jeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Detecting Alzheimer's disease using digital virtual reality cognitive tests
Lili Fang, Xiang Fan, Anqi Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies
Dai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 17, 2025
Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer's disease
Guoyu Lan, Laihong Zhang, Anqi Li, et al.
Alzheimer'S Research & Therapy
|
April 16, 2024
Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
Zhen Liu, Dai Shi, Yue Cai, et al.
Science Immunology
|
May 10, 2024
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Chuan Qin, Min Zhang, Da-Peng Mou, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
Journal of Medicinal Chemistry
|
November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors
Dai-Shi Su, Junya Qu, Mark Schulz, et al.
European Journal of Pharmacology
|
September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist
Richard W Ransom, Charles M Harrell, Duane R Reiss, et al.
Page
of 23